ClinicalTrials.govpublic full text
Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer
colorectal, cancer, s-1, bevacizumab, irinotecan, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 804853
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.